Eric Forman - 06 Nov 2022 Form 4 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Vice President and COO
Signature
/s/ Eric Forman
Issuer symbol
LIXT
Transactions as of
06 Nov 2022
Net transactions value
$0
Form type
4
Filing time
09 Nov 2022, 15:57:25 UTC
Previous filing
06 Apr 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIXT Stock Options Award $0 +200,000 $0.000000 200,000 06 Nov 2022 Common 200,000 $2.00 Direct F1
holding LIXT Warrants to Purchase Common Stock 5,264 06 Nov 2022 Common 5,264 $5.70 Direct
holding LIXT Stock Options 16,667 06 Nov 2022 Common 16,667 $0.9000 Direct
holding LIXT Stock Options 16,667 06 Nov 2022 Common 16,667 $6.60 Direct
holding LIXT Stock Options 58,333 06 Nov 2022 Common 58,333 $7.14 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 6, 2022, the reporting person was granted options to purchase 200,000 shares of the issuer's common stock, exercisable for a period of 5 years at $2.00 per share, vesting 25% on the issuance date, and 25% on each anniversary date thereafter until fully vested, subject to continued service.